GuaDex
Strengthened DexTech continues to advance towards clinical trials in multiple myeloma
Despite the general price volatility, development work continues unabated in the many biotech companies on the stock exchange. One such example is DexTech, which recently...
New DexTech chairman wants to turn up the volume
With positive phase II data in castration-resistant prostate cancer and...
DexTech Medical's CEO on the company's platform technology
Report-related DexTech Medical develops drug candidates in oncology that...
Intervju
DexTech's technology platform creates potential for more licensing deals
DexTech's patented technology platform GuaDex, which underpins both...